Latest news
Eli Lilly: 'Strong Buy' On Retatrutide Obesity Drug And EBGLYSS Maintenance Label Expansion - Seeking AlphaSeeking Alpha · Fri, 07 Aug 2026 22:29:17 GMTObesity rates have doubled in England since 1993 - what's going on? - BBCBBC · Fri, 07 Aug 2026 18:38:46 GMTBMI or Waist Circumference Rivals Lancet Obesity Definition - MedscapeMedscape · Fri, 07 Aug 2026 15:07:41 GMTWhat Direction for Obesity Policy? Where Innovation, Wicked Issues and Many Actors Collide - The King's FundThe King's Fund · Fri, 07 Aug 2026 10:11:50 GMTPfizer: Q2 Strength Overshadows Obesity Setbacks (NYSE:PFE) - Seeking AlphaSeeking Alpha · Thu, 06 Aug 2026 13:59:48 GMTLilly beats estimates on resilient demand for injectable GLP-1 drugs, widens gap with Novo - ReutersReuters · Wed, 05 Aug 2026 17:51:09 GMTLilly’s obesity pill Foundayo ‘disappointed’ in Q2, as injectables continue to boom - Fierce PharmaFierce Pharma · Wed, 05 Aug 2026 15:42:35 GMTAmgen drops ph. 1 obesity drug, upping pressure on MariTide - Fierce BiotechFierce Biotech · Tue, 04 Aug 2026 20:23:55 GMT